Stock listing
Vitrafy Life Sciences Ltd.
Selected listing: VFY · ASX · AUD · AU
Vitrafy Life Sciences Ltd. (ASX:VFY), Health Technology. Latest release Sep 30, 2026: Vitrafy enters partnership with Versiti Blood Health.
- Ticker
- ASX:VFY
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- ASX
- Currency
- AUD
About Vitrafy Life Sciences Ltd.
Vitrafy Life Sciences Ltd. (ticker: VFY) is a public company based in Australia, focused on developing innovative solutions in the life sciences sector. The company is dedicated to advancing health and wellness through its research and product offerings.
Latest news from Vitrafy Life Sciences Ltd.
Vitrafy enters partnership with Versiti Blood Health
September 29, 2026
S&P DJI Announces September 2026 Quarterly Rebalance
September 4, 2026
Vitrafy enters U.S. Cell & Gene Therapy Market
September 1, 2026
FY26 Full Year Results Presentation
August 3, 2026
Q4 FY26 Quarterly Activities Report and Appendix 4C
July 28, 2026
Research Vitrafy Life Sciences Ltd.
Vitrafy Life Sciences Ltd. company profile
View the public company page for Vitrafy Life Sciences Ltd. on 6ix.
Vitrafy Life Sciences Ltd. news
Read company news and market updates connected to Vitrafy Life Sciences Ltd..
Vitrafy Life Sciences Ltd. investor events
Find investor webinars, events, and replay context for Vitrafy Life Sciences Ltd..